UCB announces start of Phase I study for antibody drug candidate CDP6038 (03 Dec 2008) S.A. Belgium Pharma/DrugDevelopment Research News...
UCB announced that its CDP6038 antibody drug candidate targeting IL-6 has... of clinical development since UCB NewMedicines, UCB's discovery research through...
Oxford Genome Sciences Changes its Name to Oxford BioTherapeutics (03 Dec 2008) and development of targeted antibody medicines to address large and unmet patient needs... in the development of antibody therapeutics to create an exciting pipeline... and for the development of companion diagnostic products aimed at improving the diagnosis...